Santen Pharmaceutical (OTC:SNPHY) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.12 by 8.33 percent. This is a 8.33 percent decrease over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $431.325 million which beat the analyst consensus estimate of $418.770 million by 3.00 percent. This is a 9.29 percent decrease over sales of $475.523 million the same period last year.